Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

Aker ASA (AKER)

Verdict history · AKER

Every call Verdix has made on AKER.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

Click any date below to read that write-up

See methodology for how verdicts are produced. Full track record →

The panel’s case against AKER — and where they disagree.

SellHIGH confidence

The case against outweighs the case for at today's price.

OSL · Industrials / Diversified Holding Company · 2026-08-22 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Sell

HIGH confidence

Why

Six distinct investing frameworks converge on the same conclusion for Aker ASA at 1,488 NOK: the stock has run past every analyst target, erased its historical NAV discount, and prices in an AI future that declining earnings do not support. The debate among the panel is not direction but depth, with fair-value estimates spanning 900 to 1,300 NOK, and whether Nscale can deliver real revenue before the narrative exhausts itself.

Level to watch

Key support 1,299.67

−12.7% from 1,488

Next catalyst

Trigger to confirm the breakdown: A weekly close below the 20-week EMA near 1,225 would confirm that the trend is reversing from overbought extremes and that the low-volume rally above 1,400 has exhausted itself.

The panel's take

Verdict: SELL · Conviction: HIGH · Last price: 1488.0

Panel: 0 Bullish · 0 Neutral · 6 Bearish → SELL

What changed since 2026-08-15:

  • Price: 1440.0 → 1488.0 (+3.33%)
  • Panel: 0 of 6 → 0 of 6 now Bullish — composition also changed: added The Moat Compounder, The Structural Tailwind Rider; removed The Asymmetric Bargainer, The Macro Opportunist
  • Trigger: A pullback into the 1,200–1,260 zone where the stock would trade at a 15–20% discount to NAV and analyst consensus provides support, combined with evidence that Nscale is generating material revenue and the expected EPS decline reverses. Without that fundamental improvement, even a pullback only merits WAIT, not BUY.
  • Verdict: SELL (unchanged)

The stock climbed another 3.3 percent since the August SELL call at 1,440, yet the bullish trigger that might have flipped the verdict never materialized. Price did close above the 1,444 trigger level, but weekly volume came in at a tepid 1.05 times average and the MACD histogram narrowed rather than expanded, confirming no institutional surge behind the move. With no Nscale IPO filing, no debt reduction, and no reversal in the expected EPS decline, the stock has simply drifted deeper into overbought territory, hardening what was a medium-conviction SELL into a high-conviction one.

All six voices are bearish at 1,488 NOK: the stock trades above every analyst target (high 1,470, mean 1,215) and at NAV (1,478), leaving zero margin of safety. Monthly RSI at 86, expected EPS declines of 13% over three years, a leveraged balance sheet with ~40B NOK in net debt, and an AI narrative already fully priced in. The prior trigger is NOT FIRED — price did close above 1,444, but weekly volume at 1.05x average is not surging, the MACD histogram is narrowing not expanding, and there is no Nscale IPO filing or debt reduction.

Key levels

Key levels · AKER

NOK · as of 2026-08-22
Analyst consensus 1,215.5
S11,299.67
−12.7%
S21,259.55
−15.4%
S31,225.1
−17.7%
NOW
1,488

Analyst consensus target 1,215.5 NOK · range 651.45–1,470

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

Price at 1,488 is pinned at the all-time high with no overhead resistance — pure price discovery. Key support rests at 1,299.67 (weekly Fibonacci 23.6% retracement of the 690–1,488 rally), with the monthly 23.6% at 1,259.55 and the weekly EMA20 at 1,225.10 forming a dense band. The analyst consensus target of 1,215.50 sits inside this zone, reinforcing it as the region where fundamental value would re-emerge. Deeper support lies at 1,142 (prior weekly horizontal resistance, now support) and 1,118.22 (monthly Fibonacci 38.2%). No resistance levels exist above current price — the stock is in a low-volume vacuum with zero historical liquidity at these levels.

What legendary investors think

We ran Aker ASA past a panel of 6 legendary investors' frameworks.

The panel · 6 investors

🟢
0
Bullish
⚫
0
Neutral
🔴
6
Bearish
The Moat CompounderValue/Quality/Moat🔴 BearishLow

Signal: At 1,488 NOK, the stock trades at net asset value of 1,478 per share, offering zero margin of safety for a holding company whose conglomerate structure inherently lacks pricing power, switching costs, or any durable competitive advantage. Conviction: Conviction is held back because normalized free cash flow estimates vary widely across sources, and without reliable forward earnings data, the precise degree of overvaluation remains an inference rather than a calculation.

The Intrinsic-Value ModelerValuation/DCF🔴 BearishLow

Signal: Even under my most generous bull scenario applying only a 5% NAV discount, the stock would be worth 1,404 NOK — the current price of 1,488 sits above every analyst target, including the Street-high of 1,470, and requires NAV to have already grown beyond the latest reported 1,478. Conviction: What keeps confidence in check is the reality that Nscale's $790 million financing could translate into real contract wins that swell NAV beyond current marks, though the burden of proof sits squarely with the company.

The GARP OperatorGrowth (GARP)🔴 BearishLow

Signal: With consensus expecting EPS to decline roughly 13% over three years, the P/E of 23x is impossible to justify under any PEG framework: a stock with falling earnings is either a turnaround you avoid until proof appears or a cyclical you time perfectly, and this is neither. Conviction: Confidence firms up because three independent signals rarely align this cleanly: negative earnings growth that voids the PEG framework, a stock price above net asset value, and a monthly RSI of 86 that screams exhaustion.

The Forensic SkepticContrarian/Forensic🔴 BearishLow

Signal: The TTM operating cash flow of 4.9 billion NOK diverges from reported net income by a staggering 22.7 billion, exposing earnings massively inflated by non-recurring investment revaluations that mask a leveraged balance sheet carrying 42.7 billion in debt against only 2.9 billion in cash. Conviction: Multiple hard-to-dispute facts reinforce the bearish read, from the 22.7 billion NOK gap between operating cash flow and net income to the stock exceeding every analyst price target.

The Quality RationalistMental Models/Quality🔴 BearishMed

Signal: Aker ASA lacks any durable competitive advantage at the parent level: no pricing power, no switching costs, no network effects, and I cannot look through a complex conglomerate spanning oil services, renewables, and financial assets without an army of analysts. Conviction: The case is strengthened by the sheer improbability of the outcome being priced in: a leveraged conglomerate with no moat must execute flawlessly on an AI buildout just to grow into a valuation that already sits above all professional targets.

The Structural Tailwind RiderGrowth / Structural Themes🔴 BearishLow

Signal: The stock has rallied 115% from its 52-week low and now sits above every single analyst price target, with the mean consensus of 1,215 implying 18% downside from 1,488, yet fundamentals are deteriorating with expected EPS declines and shrinking margins. Conviction: Conviction hovers near neutral because the AI narrative, while fully discounted, can still inflate further on momentum alone; stocks can stay irrational longer than a bear can stay solvent.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • All six frameworks are bearish: the stock trades at or above its last reported NAV of 1,478 NOK, eliminating the historical conglomerate discount entirely.
  • Every analyst price target sits below the current price (Street-high 1,470, mean 1,215), meaning no professional model justifies 1,488 today.
  • Monthly RSI at 86 is an extreme overbought reading, and the rally above 1,400 occurred on declining volume with a narrowing MACD histogram.
  • Consensus expects EPS to decline roughly 13% over the next three years; earnings are going the wrong direction while the stock has doubled.
  • The Nscale AI data-center narrative is real but already priced in: the $790 million financing headline propelled the stock from 690 to 1,488, leaving no undiscovered catalyst to sustain the move.

The real debate

  • The Forensic Skeptic and The Quality Rationalist see intrinsic value in the 900 to 1,100 range, arguing the balance sheet leverage and poor earnings quality demand a much deeper discount than a simple NAV haircut. The Intrinsic-Value Modeler and The GARP Operator would reassess at 1,200 to 1,300, where a 15 to 20 percent discount to NAV reopens a margin of safety.
  • The Intrinsic-Value Modeler treats Nscale as a genuine catalyst whose financing could translate into real NAV growth over time, while The Forensic Skeptic views it as a narrative mask obscuring TTM earnings that are 22.7 billion NOK above operating cash flow.
  • The Moat Compounder rejects the entire structure on principle, arguing that no holding company without a durable moat merits a premium to NAV regardless of the story, while The Structural Tailwind Rider acknowledges the AI theme could keep inflating the stock on momentum alone even though fundamentals do not support it.

The question it comes down to: Can Nscale generate enough real contracted revenue to grow NAV above 1,500 before the AI infrastructure narrative cools and the stock mean-reverts toward the analyst consensus of 1,215?

The bottom line

  • Trigger to confirm the breakdown: A weekly close below the 20-week EMA near 1,225 would confirm that the trend is reversing from overbought extremes and that the low-volume rally above 1,400 has exhausted itself.
  • Next catalyst: The Q3 NAV report: if net asset value prints below 1,400, the stock loses its last valuation anchor with no discount to cushion the fall, and an accelerated repricing toward analyst consensus becomes the base case.
  • Risk to monitor: Nscale announces a major customer contract or an IPO filing that proves the AI narrative has commercial substance, which could temporarily extend the rally despite stretched valuations and keep the stock elevated longer than fundamentals suggest.
  • Key support zone: A pullback into the 1,200 to 1,260 range, where the stock would trade at a 15 to 20 percent discount to NAV and analyst consensus provides a floor, is the level at which several panel members would revisit the thesis.

contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in AKER · AKER verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of AKER's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.